IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Vestal Point Capital, LP

Portfolio Profile

CIK: 0001974915 | NEW YORK, NY

Investment Profile

Style

Core

Turnover

Very High

Orientation

Concentrated trader
$4.3B
AUM
68
Positions
50.29%
Top 10 Conc.
80.28%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1BioMarin Pharmaceutical Inc(BMRN)6,025,000$344.8M8.06%
2Neurocrine Biosciences Inc(NBIX)1,880,000$316.8M7.40%
3Abivax SA(ABVX)2,349,443$313.1M7.32%
4United Therapeutics Corp(UTHR)435,000$235.7M5.51%
5Enliven Therapeutics Inc(ELVN)4,000,000$203.0M4.74%

Sector Allocation

Latest filing, equity positions only

Healthcare96.22% · $4.1B
Unclassified3.78% · $161.9M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare97.11%96.22%-0.89%
Unclassified2.89%3.78%+0.89%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$944.0M | 48 pos.
$1.2B | 58 pos.
$1.3B | 60 pos.
$1.3B | 69 pos.
$1.7B | 73 pos.
$1.4B | 63 pos.
6
Nurix Therapeutics Inc(NRIX)
8,050,000
$195.3M
4.56%
7Bicara Therapeutics Inc(BCAX)5,250,000$155.9M3.64%
8Taysha Gene Therapies Inc(TSHA)19,415,000$132.2M3.09%
9Arrowhead Pharmaceuticals Inc(ARWR)1,575,000$128.4M3.00%
10Abbott Laboratories(ABT)1,400,000$127.0M2.97%
Cap SizePrev %Curr %Change
Large Cap32.45%41.56%+9.11%
Small Cap30.15%28.55%-1.6%
Mid Cap32.91%22.71%-10.2%
Unclassified2.89%3.78%+0.89%
Mega Cap0.55%1.99%+1.44%
Micro Cap1.06%1.39%+0.33%
$1.9B | 72 pos.
$2.2B | 81 pos.
$2.9B | 76 pos.
$3.6B | 90 pos.
$4.3B | 68 pos.
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

10
New
32
Closed
31
Increased
22
Decreased
5
Unchanged